FinalDose

Altrincham, United Kingdom

FinalDose develops programmable DNA therapeutics that eliminate diseased cells by targeting pathogenic genetic sequences.

Jun 2026

Pre-Seed

Top Investors

Y CombinatorFounder Factor

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are FinalDose's investors?

FinalDose's investors include Y Combinator, Founder Factor.

Where is FinalDose headquartered?

FinalDose is headquartered in Altrincham, United Kingdom.

What does FinalDose do?

FinalDose develops programmable DNA therapeutics that eliminate diseased cells by targeting pathogenic genetic sequences.

What stage is FinalDose at?

FinalDose is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 16, 2026.

MLA

"FinalDose — Funding & Investors." VCBacked, June 16, 2026, https://www.vcbacked.co/company/finaldose. Accessed June 30, 2026.

APA

VCBacked. (2026). FinalDose — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/finaldose

Wikipedia (cite web)

{{cite web |title=FinalDose — Funding & Investors |url=https://www.vcbacked.co/company/finaldose |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 16, 2026.